Mr Andrew E Petroll, MD | |
9200 W Wisconsin Ave, Division Of Infectious Diseases, Milwaukee, WI 53226-3522 | |
(414) 805-6444 | |
(414) 805-6702 |
Full Name | Mr Andrew E Petroll |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 23 Years |
Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013964022 | NPI | - | NPPES |
34843800 | Medicaid | WI | |
1013964022 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 45730 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
News Archive
An automated text messaging system increases patient engagement with home-based exercise and promotes faster recovery after total knee or hip replacement surgery, reports a study in the January 16, 2019 issue of The Journal of Bone & Joint Surgery.
Scripps Translational Science Institute (STSI) will present its fifth annual educational conference exploring the latest achievements and challenges in the use of genomics to diagnose and treat disease and medical conditions on March 1-2, 2012, in San Diego.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.
› Verified 6 days ago
Entity Name | The Medical College Of Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
An automated text messaging system increases patient engagement with home-based exercise and promotes faster recovery after total knee or hip replacement surgery, reports a study in the January 16, 2019 issue of The Journal of Bone & Joint Surgery.
Scripps Translational Science Institute (STSI) will present its fifth annual educational conference exploring the latest achievements and challenges in the use of genomics to diagnose and treat disease and medical conditions on March 1-2, 2012, in San Diego.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Andrew E Petroll, MD 9200 W Wisconsin Ave, Division Of Infectious Diseases, Milwaukee, WI 53226-3522 Ph: (414) 805-6444 | Mr Andrew E Petroll, MD 9200 W Wisconsin Ave, Division Of Infectious Diseases, Milwaukee, WI 53226-3522 Ph: (414) 805-6444 |
News Archive
An automated text messaging system increases patient engagement with home-based exercise and promotes faster recovery after total knee or hip replacement surgery, reports a study in the January 16, 2019 issue of The Journal of Bone & Joint Surgery.
Scripps Translational Science Institute (STSI) will present its fifth annual educational conference exploring the latest achievements and challenges in the use of genomics to diagnose and treat disease and medical conditions on March 1-2, 2012, in San Diego.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.
› Verified 6 days ago
Julia Bonner, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Dr. Jeffrey Wilson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, Ste 206, Milwaukee, WI 53233 Phone: 414-219-7136 | |
Rasika Surajyam Chepuri, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 |